Skip to content

John Bennett

Partner

Boston

Image of John Bennett
John Bennett

Partner

Boston

John is a partner in the Intellectual Property practice in the Boston Office who focuses on representing innovators in the life science industry. He has nearly 20 years of first-chair trial experience in high-stakes intellectual property and technology disputes. John’s experience includes numerous trial representations in cases brought under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act as well as trade secret, licensing and contract disputes. Clients praise John for his “unique understanding of the interplay between IP, regulatory, and business issues in the pharmaceutical sector” and regularly turn to him for advice regarding patents, exclusivities and litigation risk concerning commercial and late-stage clinical assets.

John’s engagements have included trial representation before various federal courts and the Patent Trial and Appeal Board, appellate representation before the Federal Circuit and other courts of appeal. His experience includes work on numerous patent and trade secret cases involving a variety of technologies including pharmaceuticals, biotechnology, medical devices, telecommunications and internet content delivery systems. John also is frequently asked to conduct diligence, render opinions and perform freedom to operate analyses.

John actively engages in pro bono work, including appearing as lead counsel in federal litigation against the U.S. Government, which led to the release of Francisco Rodriguez-Guardado, a longtime Massachusetts Institute of Technology custodian and father of three U.S. citizen children, who was suddenly incarcerated and threatened with deportation in 2017-2018.

Experience highlights

Related articles

Close-up medical syringe with a vaccine

Blog Post: 23 May 2023

PTAB decision invalidating claims as obvious based on analogous art reversed by Federal Circuit

Procedural History Sanofi-Aventis Deutschland GMBH v. Mylan Pharmaceuticals Inc. is an appeal from a final written decision in an inter partes proceeding (“IPR”) of the Patent Trial and Appeal Board…

Read more PTAB decision invalidating claims as obvious based on analogous art reversed by Federal Circuit

Blog Post: 22 May 2023

United States Supreme Court affirms invalidating claims for lack of enablement

Read more United States Supreme Court affirms invalidating claims for lack of enablement

Blog Post: 01 May 2023

District Court Invalidation of Parkinson's Drug Patent as Obvious Affirmed by Federal Circuit

Read more District Court Invalidation of Parkinson's Drug Patent as Obvious Affirmed by Federal Circuit

Blog Post: 20 April 2023

PTAB decision invalidating claims as inherently anticipated upheld by Federal Circuit

Read more PTAB decision invalidating claims as inherently anticipated upheld by Federal Circuit

Expertise

Practices

Intellectual Property

Sectors

Life Sciences

Office

Boston

One Beacon Street
Boston
MA 02108

View office →

Qualifications

Professional

Admitted to the Bar of the State of Massachusetts, 2001

U.S. Court of Appeals for the Federal Circuit

U.S. Court of Appeals for the First Circuit

U.S. Court of Appeals for the Fifth Circuit

U.S. Court of Appeals for the Tenth Circuit

U.S. District Court for the District of Massachusetts

Academic

JD, Boston College Law School, 2000

B.A., Dartmouth College, cum laude with high honors, B.A., 1996

Recognition